Why the study?
Platelet count, indices, and aggregation are widely used to assess primary hemostasis, but the influence of time since blood draw and anticoagulant type requires systematic evaluation.
How do the time-interval since blood draw and the type of anticoagulation affect platelet count, indices, and aggregation in healthy volunteers?
How do the time-interval since blood draw and the type of anticoagulation affect platelet count, indices, and aggregation in healthy volunteers?
Preanalytical variables such as time since blood draw and type of anticoagulant significantly affect platelet testing results, highlighting the need for standardized preanalytical conditions.
Answers are grounded in this paper and cite their sources.
Requires standardized preanalytical conditions for reliable aggregometry; leaves optimal timing and anticoagulant open for validation.
Platelet count, indices (mean volume, young—immature platelet fraction) and aggregation are widely used laboratory parameters to investigate primary hemostasis. We performed a systematic, thorough evaluation of the influence of the time-interval since blood draw from 20 healthy individuals and of the anticoagulation of collected blood on such parameters. Blood was anticoagulated with citrate, K2-ethylenediaminetetraacetic acid (EDTA) and hirudin and analyzed 5, 30, 60, 120 and 180 min after blood draw. Multiple electrode aggregometry (MEA) was performed with either hirudin (half-diluted with NaCl) or citrate samples (half-diluted with NaCl or CaCl2 3 mM). Platelet count and indices (Sysmex XN-20) were rather stable over time with EDTA blood. MEA results were lower with citrate blood than with hirudin blood; supplementation with calcium was partially compensatory. MEA results were also lower when performed less than 30 or more than 120 min after blood draw. Platelet clumping, quantitatively estimated with microscope examination of blood smears, was more important in hirudin blood than citrate or EDTA blood and could explain some of the differences observed between preanalytical variables. The results stress once more the importance of preanalytical variables in hemostasis laboratory testing. Decision thresholds based on those tests are only applicable within specific preanalytical conditions.
No takes yet. Share an insight, caveat, or question.
Hardy et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: